Condition: Acute Lymphoblastic Leukemia · Sponsor: MSD R&D (China) Co., Ltd.
Researchers are looking for new ways to treat people with a type of blood cancer called precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) that is relapsed- the cancer has come back after treatment, or refractory - the current treatment has stopped working to slow or stop cancer growth. This study will have two parts. In the first part (dose escalation phase) the goal is to learn about the safety of a study treatment, MK-1045, and to find the best dose level of MK-1045 that is tolerated and may work to treat B-ALL. In the second part (Phase II) researchers want to learn how well MK-1045 works to treat B-ALL.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Third Military Medical University ( Site 0008) | Chongqing, Chongqing Municipality, China | Recruiting |
| Southern Medical University Nanfang Hospital ( Site 0004) | Guangzhou, Guangdong, China | Recruiting |
| The Second Hospital of Hebei Medical University ( Site 0003) | Shijiazhuang, Hebei, China | Recruiting |
| The First Hospital of Harbin ( Site 0005) | Harbin, Heilongjiang, China | Recruiting |
| Henan Cancer Hospital-hematology department ( Site 0002) | Zhengzhou, Henan, China | Recruiting |
| Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology ( Site 0010) | Wuhan, Hubei, China | Recruiting |
| Tongji Hospital affiliated to Tongji Medical College of HUST ( Site 0006) | Wuhan, Hubei, China | Recruiting |
| The Affiliated Hospital of Xuzhou Medical University ( Site 0007) | Xuzhou, Jiangsu, China | Active Not Recruiting |
| West China Second University Hospital, Sichuan University ( Site 0011) | Chengdu, Sichuan, China | Completed |
| Hematology Hospital of Chinese Academy of Medical Sciences ( Site 0001) | Tianjin, Tianjin Municipality, China | Recruiting |
| The Children's Hospital of Zhejiang University School of Medicine ( Site 0009) | Hangzhou, Zhejiang, China | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05579132